DALBAVANCIN

DALBAVANCIN was reported 1005 times

These side effects are most commonly reported by patients taking DALBAVANCIN:

# Side effect Count
0 OFF LABEL USE 148
1 RASH 96
2 BACK PAIN 59
3 PRURITUS 59
4 DRUG INEFFECTIVE 58
5 NAUSEA 57
6 DYSPNOEA 54
7 VOMITING 51
8 HYPERSENSITIVITY 46
9 ERYTHEMA 42
10 URTICARIA 39
11 PYREXIA 35
12 DIARRHOEA 30
13 INFUSION RELATED REACTION 30
14 CHEST DISCOMFORT 28
15 CHILLS 26
16 ANAPHYLACTIC REACTION 25
17 CHEST PAIN 24
18 PRODUCT PREPARATION ERROR 24
19 PRODUCT STORAGE ERROR 24
20 MUSCLE SPASMS 22
21 FLUSHING 21
22 INFUSION SITE EXTRAVASATION 21
23 ACUTE KIDNEY INJURY 20
24 PERIPHERAL SWELLING 18
25 DIZZINESS 17
26 PAIN 17
27 DRUG HYPERSENSITIVITY 16
28 HYPERHIDROSIS 16
29 PAIN IN EXTREMITY 16
30 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 16
31 DEATH 15
32 MALAISE 15
33 THROAT IRRITATION 14
34 HEADACHE 13
35 TREMOR 13
36 CELLULITIS 12
37 FEELING HOT 12
38 HYPOTENSION 12
39 LOSS OF CONSCIOUSNESS 12
40 PRODUCT USE IN UNAPPROVED INDICATION 11
41 STAPHYLOCOCCAL INFECTION 11
42 ASTHENIA 10
43 BLISTER 10
44 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 10
45 SEPSIS 10
46 THROMBOCYTOPENIA 10
47 ARTHRALGIA 9
48 DRUG RESISTANCE 9
49 INCORRECT DOSE ADMINISTERED 9
50 LIP SWELLING 9
51 PATHOGEN RESISTANCE 9
52 RASH MACULAR 9
53 SEIZURE 9
54 TACHYCARDIA 9
55 ANGIOEDEMA 8
56 CONDITION AGGRAVATED 8
57 DECREASED APPETITE 8
58 HEPATOTOXICITY 8
59 INFECTION 8
60 INFUSION SITE PAIN 8
61 INJECTION SITE PAIN 8
62 NEUTROPENIA 8
63 OXYGEN SATURATION DECREASED 8
64 THROAT TIGHTNESS 8
65 ABDOMINAL PAIN UPPER 7
66 BLOOD PRESSURE INCREASED 7
67 FEELING ABNORMAL 7
68 FLANK PAIN 7
69 HYPERTENSION 7
70 PALLOR 7
71 PRURITUS GENERALISED 7
72 RENAL FAILURE 7
73 SKIN DISCOLOURATION 7
74 SKIN EXFOLIATION 7
75 WEIGHT DECREASED 7
76 ABDOMINAL DISCOMFORT 6
77 ACUTE RESPIRATORY FAILURE 6
78 ADVERSE DRUG REACTION 6
79 ANAPHYLACTIC SHOCK 6
80 BLOOD PRESSURE DECREASED 6
81 CYANOSIS 6
82 FATIGUE 6
83 FEELING COLD 6
84 INFUSION SITE SWELLING 6
85 SWELLING 6
86 SWELLING FACE 6
87 SWOLLEN TONGUE 6
88 THERAPEUTIC PRODUCT CROSS-REACTIVITY 6
89 ANXIETY 5
90 ATRIAL FIBRILLATION 5
91 BLOOD CREATININE INCREASED 5
92 CONTUSION 5
93 DEEP VEIN THROMBOSIS 5
94 DISCOMFORT 5
95 EOSINOPHILIA 5
96 EYE SWELLING 5
97 GAIT DISTURBANCE 5
98 GAIT INABILITY 5
99 HOSPITALISATION 5
100 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 5
101 INJECTION SITE EXTRAVASATION 5
102 LEUKOPENIA 5
103 LIVER FUNCTION TEST INCREASED 5
104 MUSCULAR WEAKNESS 5
105 MYALGIA 5
106 OEDEMA PERIPHERAL 5
107 OSTEOMYELITIS 5
108 PARAESTHESIA 5
109 PNEUMONIA 5
110 POOR QUALITY PRODUCT ADMINISTERED 5
111 PRODUCT PREPARATION ISSUE 5
112 RASH PRURITIC 5
113 RENAL TUBULAR NECROSIS 5
114 THROMBOSIS 5
115 ABDOMINAL PAIN 4
116 ADVERSE EVENT 4
117 ALOPECIA 4
118 ARTHRITIS INFECTIVE 4
119 BACTERAEMIA 4
120 BLOOD GLUCOSE INCREASED 4
121 BONE PAIN 4
122 DEAFNESS NEUROSENSORY 4
123 DRUG ERUPTION 4
124 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 4
125 DYSPHONIA 4
126 ENDOCARDITIS 4
127 HAEMATOTOXICITY 4
128 HYPOAESTHESIA 4
129 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 4
130 INFLAMMATION 4
131 INFUSION SITE ERYTHEMA 4
132 LACTIC ACIDOSIS 4
133 MULTIPLE-DRUG RESISTANCE 4
134 PHARYNGEAL SWELLING 4
135 PRODUCT DOSE OMISSION ISSUE 4
136 PRODUCT QUALITY ISSUE 4
137 RASH ERYTHEMATOUS 4
138 RASH MACULO-PAPULAR 4
139 RHABDOMYOLYSIS 4
140 SYNCOPE 4
141 THERAPY CESSATION 4
142 TREATMENT FAILURE 4
143 VANCOMYCIN INFUSION REACTION 4
144 WHITE BLOOD CELL COUNT INCREASED 4
145 ABSCESS 3
146 ANAEMIA 3
147 BRONCHOSPASM 3
148 BURNING SENSATION 3
149 CARDIOVASCULAR DISORDER 3
150 CLOSTRIDIUM DIFFICILE COLITIS 3
151 COAGULATION TIME ABNORMAL 3
152 COLD SWEAT 3
153 COUGH 3
154 COVID-19 3
155 EAR PRURITUS 3
156 EXTRAVASATION 3
157 FALL 3
158 HAEMORRHAGE 3
159 HEPATITIS 3
160 HYPERTRIGLYCERIDAEMIA 3
161 HYPERVENTILATION 3
162 HYPOXIA 3
163 ILLNESS 3
164 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 3
165 INFUSION SITE NODULE 3
166 INFUSION SITE REACTION 3
167 INJECTION SITE ERYTHEMA 3
168 INTERNATIONAL NORMALISED RATIO INCREASED 3
169 LEUKOCYTOSIS 3
170 LIQUID PRODUCT PHYSICAL ISSUE 3
171 LOCALISED INFECTION 3
172 MATERNAL EXPOSURE DURING PREGNANCY 3
173 MUSCLE TIGHTNESS 3
174 MUSCULOSKELETAL DISCOMFORT 3
175 NECK PAIN 3
176 PHARYNGEAL OEDEMA 3
177 PLATELET COUNT DECREASED 3
178 PRODUCT USE ISSUE 3
179 RED MAN SYNDROME 3
180 RENAL IMPAIRMENT 3
181 RESPIRATORY ARREST 3
182 SINUS TACHYCARDIA 3
183 SKIN LACERATION 3
184 STAPHYLOCOCCAL BACTERAEMIA 3
185 STEVENS-JOHNSON SYNDROME 3
186 TOXIC SKIN ERUPTION 3
187 TUBULOINTERSTITIAL NEPHRITIS 3
188 UNEVALUABLE EVENT 3
189 URINE ABNORMALITY 3
190 VOMITING PROJECTILE 3
191 ABDOMINAL ABSCESS 2
192 ABDOMINAL DISTENSION 2
193 ADMINISTRATION SITE EXTRAVASATION 2
194 ANAL INCONTINENCE 2
195 ANAPHYLACTOID REACTION 2
196 ATAXIA 2
197 BLOOD SODIUM DECREASED 2
198 BLOOD URINE PRESENT 2
199 BONE DISORDER 2
200 BREATH HOLDING 2
201 CARDIAC ARREST 2
202 CEREBROVASCULAR ACCIDENT 2
203 CLOSTRIDIUM DIFFICILE INFECTION 2
204 CONSTIPATION 2
205 CROSS SENSITIVITY REACTION 2
206 DEHYDRATION 2
207 DIABETES MELLITUS 2
208 DRUG INTERACTION 2
209 DRUG INTOLERANCE 2
210 EPISTAXIS 2
211 FLATULENCE 2
212 FOAMING AT MOUTH 2
213 FUNGAL INFECTION 2
214 GANGRENE 2
215 GASTROINTESTINAL DISORDER 2
216 GLOSSITIS 2
217 GRANULOMA ANNULARE 2
218 HAEMOPTYSIS 2
219 HALLUCINATION 2
220 HEART RATE INCREASED 2
221 HYPERTENSIVE CRISIS 2
222 HYPERTRANSAMINASAEMIA 2
223 HYPOACUSIS 2
224 HYPONATRAEMIA 2
225 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
226 INCORRECT DRUG ADMINISTRATION DURATION 2
227 INFUSION SITE HAEMORRHAGE 2
228 INFUSION SITE RASH 2
229 INFUSION SITE THROMBOSIS 2
230 INJECTION SITE DISCOLOURATION 2
231 INJECTION SITE MASS 2
232 INJECTION SITE SWELLING 2
233 INJECTION SITE WARMTH 2
234 INSOMNIA 2
235 LABORATORY TEST ABNORMAL 2
236 MIGRAINE 2
237 MIXED LIVER INJURY 2
238 MULTIPLE USE OF SINGLE-USE PRODUCT 2
239 MUSCULOSKELETAL PAIN 2
240 NEOPLASM MALIGNANT 2
241 OEDEMA 2
242 OROPHARYNGEAL DISCOMFORT 2
243 OTOTOXICITY 2
244 PANCYTOPENIA 2
245 PERIPHERAL VENOUS DISEASE 2
246 PHLEBITIS 2
247 POST PROCEDURAL INFECTION 2
248 PRESYNCOPE 2
249 PRODUCT COLOUR ISSUE 2
250 PRODUCT PRESCRIBING ERROR 2
251 PRODUCT RECONSTITUTION QUALITY ISSUE 2
252 PSEUDOMONAS INFECTION 2
253 PURULENT DISCHARGE 2
254 RASH GENERALISED 2
255 RENAL CYST 2
256 RESPIRATORY DISTRESS 2
257 RETCHING 2
258 SEASONAL ALLERGY 2
259 SINUS DISORDER 2
260 SKIN DISORDER 2
261 SKIN INFECTION 2
262 SKIN REACTION 2
263 SKIN ULCER 2
264 SPINAL PAIN 2
265 STREPTOCOCCAL INFECTION 2
266 STRESS 2
267 SUICIDAL IDEATION 2
268 SUSPECTED PRODUCT CONTAMINATION 2
269 TENDON RUPTURE 2
270 TINNITUS 2
271 TRANSAMINASES INCREASED 2
272 TYPE IV HYPERSENSITIVITY REACTION 2
273 UNRESPONSIVE TO STIMULI 2
274 UPPER RESPIRATORY TRACT INFECTION 2
275 URINARY INCONTINENCE 2
276 URINARY TRACT INFECTION 2
277 VASCULITIS 2
278 VEIN DISORDER 2
279 VISION BLURRED 2
280 WOUND INFECTION 2
281 ABDOMINAL TENDERNESS 1
282 ACCIDENTAL EXPOSURE TO PRODUCT 1
283 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1
284 ADMINISTRATION SITE CELLULITIS 1
285 ADMINISTRATION SITE PAIN 1
286 ADMINISTRATION SITE SWELLING 1
287 ADMINISTRATION SITE WARMTH 1
288 ADVERSE REACTION 1
289 AGGRESSION 1
290 AGRANULOCYTOSIS 1
291 ALANINE AMINOTRANSFERASE INCREASED 1
292 AMENORRHOEA 1
293 AMPHETAMINES POSITIVE 1
294 AMPUTEE 1
295 ANORECTAL DISCOMFORT 1
296 APHONIA 1
297 APPLICATION SITE ERYTHEMA 1
298 APPLICATION SITE NODULE 1
299 APPLICATION SITE PAIN 1
300 APPLICATION SITE PRURITUS 1
301 APPLICATION SITE STREAKING 1
302 APPLICATION SITE URTICARIA 1
303 APPLICATION SITE VESICLES 1
304 ARTHRITIS BACTERIAL 1
305 ASPARTATE AMINOTRANSFERASE INCREASED 1
306 ASPIRATION 1
307 ASTHMA 1
308 BACTERIAL INFECTION 1
309 BACTERIAL SEPSIS 1
310 BILIARY COLIC 1
311 BLISTER INFECTED 1
312 BLISTER RUPTURE 1
313 BLOOD BILIRUBIN INCREASED 1
314 BLOOD CREATININE ABNORMAL 1
315 BLOOD LACTIC ACID INCREASED 1
316 BLOOD PRESSURE DIASTOLIC DECREASED 1
317 BLOOD PRESSURE DIASTOLIC INCREASED 1
318 BLOOD PRESSURE IMMEASURABLE 1
319 BLOOD PRESSURE SYSTOLIC INCREASED 1
320 BLOOD TRIGLYCERIDES INCREASED 1
321 BONE NEOPLASM 1
322 BREAST CANCER 1
323 BREAST SWELLING 1
324 C-REACTIVE PROTEIN INCREASED 1
325 CANDIDA INFECTION 1
326 CARCINOMA IN SITU 1
327 CARDIAC FAILURE 1
328 CATHETER SITE IRRITATION 1
329 CATHETERISATION CARDIAC 1
330 CERVICAL VERTEBRAL FRACTURE 1
331 CERVICITIS 1
332 CHEMOTHERAPY 1
333 CHOKING 1
334 CHOLELITHIASIS 1
335 CHOLESTASIS 1
336 CHONDROCALCINOSIS 1
337 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 1
338 CHRONIC SPONTANEOUS URTICARIA 1
339 COLITIS 1
340 COMPLICATION ASSOCIATED WITH DEVICE 1
341 CONFUSIONAL STATE 1
342 CORYNEBACTERIUM INFECTION 1
343 CRYING 1
344 CUTANEOUS VASCULITIS 1
345 CYSTIC FIBROSIS LUNG 1
346 CYTOKINE RELEASE SYNDROME 1
347 DEAFNESS 1
348 DEPRESSED LEVEL OF CONSCIOUSNESS 1
349 DERMATITIS CONTACT 1
350 DEVICE BREAKAGE 1
351 DEVICE INFUSION ISSUE 1
352 DEVICE ISSUE 1
353 DEVICE RELATED SEPSIS 1
354 DIABETIC FOOT INFECTION 1
355 DIPLOPIA 1
356 DISCOLOURED VOMIT 1
357 DISEASE RECURRENCE 1
358 DISORIENTATION 1
359 DRUG ADMINISTRATION ERROR 1
360 DRUG DEPENDENCE 1
361 DRUG DOSE OMISSION 1
362 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1
363 DRUG SPECIFIC ANTIBODY PRESENT 1
364 DRUG TOLERANCE 1
365 DRUG-INDUCED LIVER INJURY 1
366 DYSPHAGIA 1
367 DYSSTASIA 1
368 EAR DISCOMFORT 1
369 EAR INFECTION 1
370 EAR SWELLING 1
371 ECCHYMOSIS 1
372 EMBOLISM 1
373 EMPYEMA 1
374 ENCEPHALOPATHY 1
375 ENTEROCUTANEOUS FISTULA 1
376 EOSINOPHIL COUNT ABNORMAL 1
377 ESCHERICHIA SEPSIS 1
378 ESCHERICHIA URINARY TRACT INFECTION 1
379 EXPIRED PRODUCT ADMINISTERED 1
380 EXPOSURE DURING PREGNANCY 1
381 EXPOSURE VIA BREAST MILK 1
382 EYE HAEMATOMA 1
383 EYE HAEMORRHAGE 1
384 EYE PAIN 1
385 EYE PRURITUS 1
386 EYELID OEDEMA 1
387 FACE OEDEMA 1
388 FAECES SOFT 1
389 FEELING JITTERY 1
390 FIBULA FRACTURE 1
391 FINE MOTOR SKILL DYSFUNCTION 1
392 FISTULA 1
393 FLUID OVERLOAD 1
394 FOOT AMPUTATION 1
395 FOOT FRACTURE 1
396 FORCED EXPIRATORY VOLUME DECREASED 1
397 FORMICATION 1
398 FURUNCLE 1
399 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1
400 GASTRIC HAEMORRHAGE 1
401 GASTROINTESTINAL HYPERMOTILITY 1
402 GASTROINTESTINAL STOMA OUTPUT INCREASED 1
403 GASTROINTESTINAL TUBE INSERTION 1
404 GASTROOESOPHAGEAL REFLUX DISEASE 1
405 GENERALISED TONIC-CLONIC SEIZURE 1
406 GINGIVAL BLEEDING 1
407 GLOMERULAR FILTRATION RATE INCREASED 1
408 GLYCOSYLATED HAEMOGLOBIN INCREASED 1
409 GREATER TROCHANTERIC PAIN SYNDROME 1
410 HAEMATURIA 1
411 HAEMOGLOBIN DECREASED 1
412 HALLUCINATION, AUDITORY 1
413 HALLUCINATION, VISUAL 1
414 HEAD DISCOMFORT 1
415 HEPATIC ENCEPHALOPATHY 1
416 HEPATIC ENZYME INCREASED 1
417 HEPATIC STEATOSIS 1
418 HEPATOSPLENOMEGALY 1
419 HERPES SIMPLEX 1
420 HIP ARTHROPLASTY 1
421 HOT FLUSH 1
422 HUMAN RHINOVIRUS TEST POSITIVE 1
423 HYPERCALCAEMIA 1
424 HYPERPHAGIA 1
425 HYPERPYREXIA 1
426 HYPERSOMNIA 1
427 HYPERVOLAEMIA 1
428 HYPOGAMMAGLOBULINAEMIA 1
429 HYPOGLYCAEMIA 1
430 HYPOKINESIA 1
431 HYPOMAGNESAEMIA 1
432 HYPOPROTHROMBINAEMIA 1
433 HYPOTHERMIA 1
434 HYPOTONIA 1
435 HYSTERECTOMY 1
436 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1
437 IMPAIRED HEALING 1
438 INCISION SITE ABSCESS 1
439 INCORRECT PRODUCT FORMULATION ADMINISTERED 1
440 INCORRECT ROUTE OF DRUG ADMINISTRATION 1
441 INCREASED UPPER AIRWAY SECRETION 1
442 INDURATION 1
443 INFECTION REACTIVATION 1
444 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 1
445 INFLAMMATORY MARKER INCREASED 1
446 INFLUENZA 1
447 INFLUENZA LIKE ILLNESS 1
448 INFUSION SITE DISCOMFORT 1
449 INFUSION SITE HAEMATOMA 1
450 INFUSION SITE HYPOAESTHESIA 1
451 INFUSION SITE IRRITATION 1
452 INFUSION SITE OEDEMA 1
453 INFUSION SITE PARAESTHESIA 1
454 INFUSION SITE PRURITUS 1
455 INFUSION SITE URTICARIA 1
456 INITIAL INSOMNIA 1
457 INJECTION SITE CELLULITIS 1
458 INJECTION SITE HAEMORRHAGE 1
459 INJECTION SITE INFECTION 1
460 INJECTION SITE RASH 1
461 INSULIN RESISTANCE 1
462 INSURANCE ISSUE 1
463 INTERCEPTED MEDICATION ERROR 1
464 INTERCEPTED PRODUCT PREPARATION ERROR 1
465 INTERNATIONAL NORMALISED RATIO ABNORMAL 1
466 INTRA-ABDOMINAL HAEMATOMA 1
467 IRRITABILITY 1
468 JAW DISORDER 1
469 JEJUNOSTOMY 1
470 JOINT NOISE 1
471 JOINT RANGE OF MOTION DECREASED 1
472 JOINT SWELLING 1
473 JUGULAR VEIN THROMBOSIS 1
474 LETHARGY 1
475 LIGAMENT SPRAIN 1
476 LIMB DEFORMITY 1
477 LIMB INJURY 1
478 LIVER FUNCTION TEST ABNORMAL 1
479 LIVER INJURY 1
480 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 1
481 LUNG CONSOLIDATION 1
482 MACULAR DEGENERATION 1
483 MALE ORGASMIC DISORDER 1
484 MASS 1
485 MEAN CELL VOLUME INCREASED 1
486 MECHANICAL VENTILATION 1
487 MEMORY IMPAIRMENT 1
488 MENTAL DISORDER 1
489 MENTAL STATUS CHANGES 1
490 METABOLIC ACIDOSIS 1
491 METABOLIC DISORDER 1
492 METABOLIC ENCEPHALOPATHY 1
493 MOBILITY DECREASED 1
494 MOUTH SWELLING 1
495 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
496 MUSCLE CONTRACTIONS INVOLUNTARY 1
497 MUSCULOSKELETAL DISORDER 1
498 MYELITIS 1
499 NASOPHARYNGITIS 1
500 NEEDLE ISSUE 1
501 NEPHRECTOMY 1
502 NEPHROPATHY TOXIC 1
503 NERVE INJURY 1
504 NERVOUS SYSTEM DISORDER 1
505 NERVOUSNESS 1
506 NEUTRALISING ANTIBODIES POSITIVE 1
507 NEUTROPHIL COUNT ABNORMAL 1
508 NEUTROPHIL COUNT INCREASED 1
509 NO ADVERSE EVENT 1
510 NOCTURNAL HYPERTENSION 1
511 NON-SMALL CELL LUNG CANCER 1
512 NORMAL NEWBORN 1
513 NOSOCOMIAL INFECTION 1
514 OROPHARYNGEAL PAIN 1
515 ORTHOSTATIC HYPERTENSION 1
516 ORTHOSTATIC HYPOTENSION 1
517 OSTEOARTHRITIS 1
518 OSTEOMYELITIS ACUTE 1
519 OVERDOSE 1
520 OVERGROWTH OF NONSUSCEPTIBLE ORGANISMS 1
521 PALPABLE PURPURA 1
522 PALPITATIONS 1
523 PANIC ATTACK 1
524 PAPULE 1
525 PARAESTHESIA ORAL 1
526 PARASPINAL ABSCESS 1
527 PELVIC PAIN 1
528 PERIORBITAL OEDEMA 1
529 PERIORBITAL PAIN 1
530 PETECHIAE 1
531 PHARYNGEAL DISORDER 1
532 PLATELET DISORDER 1
533 PNEUMONIA ASPIRATION 1
534 PNEUMONIA KLEBSIELLA 1
535 PNEUMONIA STAPHYLOCOCCAL 1
536 PNEUMOTHORAX 1
537 POLLAKIURIA 1
538 POLYARTHRITIS 1
539 POST PROCEDURAL FEVER 1
540 POSTOPERATIVE WOUND INFECTION 1
541 PREGNANCY 1
542 PREMATURE DELIVERY 1
543 PRODUCT ADMINISTRATION INTERRUPTED 1
544 PRODUCT CONTAMINATION 1
545 PRODUCT DISPENSING ERROR 1
546 PRODUCT DISPENSING ISSUE 1
547 PRODUCT DOSE OMISSION 1
548 PRODUCT DOSE OMISSION IN ERROR 1
549 PRODUCT PHYSICAL ISSUE 1
550 PROSTATIC CYST 1
551 PROSTATIC OPERATION 1
552 PROTEIN URINE PRESENT 1
553 PROTEINURIA 1
554 PULMONARY OEDEMA 1
555 PULMONARY TOXICITY 1
556 PULSE ABNORMAL 1
557 PULSELESS ELECTRICAL ACTIVITY 1
558 PURPURA 1
559 QUALITY OF LIFE DECREASED 1
560 RASH MORBILLIFORM 1
561 RASH PAPULAR 1
562 RASH VESICULAR 1
563 RECTAL HAEMORRHAGE 1
564 RED BLOOD CELL ABNORMALITY 1
565 RED BLOOD CELL COUNT DECREASED 1
566 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1
567 RED BLOOD CELLS URINE POSITIVE 1
568 RELAPSING FEVER 1
569 RENAL DISORDER 1
570 RENAL PAIN 1
571 RESPIRATORY RATE INCREASED 1
572 RESPIRATORY SYNCYTIAL VIRUS INFECTION 1
573 RESPIRATORY TRACT CONGESTION 1
574 RESTLESSNESS 1
575 SCHIZOPHRENIA 1
576 SCLERODERMA 1
577 SCRATCH 1
578 SECRETION DISCHARGE 1
579 SEDATION 1
580 SENSATION OF BLOOD FLOW 1
581 SENSATION OF FOREIGN BODY 1
582 SENSORY LOSS 1
583 SEPSIS SYNDROME 1
584 SERUM SICKNESS 1
585 SERUM SICKNESS-LIKE REACTION 1
586 SHOCK 1
587 SKIN IRRITATION 1
588 SKIN LESION 1
589 SKIN SENSITISATION 1
590 SKIN TOXICITY 1
591 SKIN WRINKLING 1
592 SPEECH DISORDER 1
593 SPINAL OPERATION 1
594 SQUAMOUS CELL CARCINOMA 1
595 STARING 1
596 STOMATITIS 1
597 STRIDOR 1
598 SUDDEN DEATH 1
599 SUICIDE ATTEMPT 1
600 SUPERFICIAL VEIN THROMBOSIS 1
601 SUPRAVENTRICULAR TACHYCARDIA 1
602 SURGERY 1
603 SUSPECTED OFF LABEL USE 1
604 SWELLING OF EYELID 1
605 SYSTEMIC INFECTION 1
606 TENDON TRANSFER 1
607 THERAPEUTIC PRODUCT EFFECT DECREASED 1
608 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1
609 THERAPEUTIC RESPONSE DECREASED 1
610 THERAPY PARTIAL RESPONDER 1
611 TINEA PEDIS 1
612 TOE AMPUTATION 1
613 TONGUE INJURY 1
614 TOXIC EPIDERMAL NECROLYSIS 1
615 TRANSFUSION 1
616 TRIGGER FINGER 1
617 TYPE 2 DIABETES MELLITUS 1
618 TYPE III IMMUNE COMPLEX MEDIATED REACTION 1
619 UNDERDOSE 1
620 UREAPLASMA INFECTION 1
621 VAGINAL DISCHARGE 1
622 VAGINAL INFECTION 1
623 VARICELLA 1
624 VASCULAR ACCESS SITE EXTRAVASATION 1
625 VASCULAR DEVICE INFECTION 1
626 VASCULAR INJURY 1
627 VASCULAR SKIN DISORDER 1
628 VENTRICULAR TACHYCARDIA 1
629 VERTIGO 1
630 VISUAL IMPAIRMENT 1
631 VULVITIS 1
632 VULVOVAGINITIS 1
633 WALKING DISABILITY 1
634 WEIGHT ABNORMAL 1
635 WHEELCHAIR USER 1
636 WHEEZING 1
637 WOUND 1
638 WOUND COMPLICATION 1
639 WOUND DEHISCENCE 1
640 WOUND SECRETION 1